What is the treatment for status asthmaticus in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Status Asthmaticus in Adults

The immediate treatment of status asthmaticus in adults requires high-flow oxygen, high-dose inhaled β-agonists, systemic corticosteroids, and consideration of adjunctive therapies such as ipratropium bromide to prevent mortality and restore lung function as quickly as possible. 1

Assessment of Severity

Status asthmaticus is defined as severe asthma unresponsive to repeated courses of beta-agonist therapy 2. Proper assessment is critical for management:

Features of Severe Asthma:

  • Too breathless to complete sentences in one breath
  • Respiratory rate >25 breaths/min
  • Peak expiratory flow (PEF) <50% of predicted normal or best
  • Heart rate >110 beats/min 1

Life-Threatening Features:

  • PEF <33% of predicted normal or best
  • Silent chest, cyanosis, or feeble respiratory effort
  • Bradycardia or hypotension
  • Exhaustion, confusion, or coma 1

Arterial Blood Gas Markers of Severity:

  • Normal or high PaCO₂ (5-6 kPa) in a breathless asthmatic
  • Severe hypoxia: PaO₂ <8 kPa despite oxygen therapy
  • Low pH (acidosis) 1

Immediate Management Algorithm

  1. High-Flow Oxygen

    • Administer immediately to maintain oxygen saturation >90% 1
  2. High-Dose Inhaled β-agonists

    • Give salbutamol 5 mg or terbutaline 10 mg via nebulizer with oxygen
    • Can be administered via multiple actuations of metered dose inhaler into spacer (2 puffs 10-20 times) if nebulizer unavailable
    • Albuterol (salbutamol) is the most commonly used β₂-selective inhaled bronchodilator 3
    • For adults, standard dose is 2.5 mg administered 3-4 times daily by nebulization 4
    • In status asthmaticus, may need to administer more frequently (up to every 15-30 minutes) 1
  3. Systemic Corticosteroids

    • Administer immediately: prednisolone 30-60 mg orally or hydrocortisone 200 mg IV 1
    • Should be given as early as possible as clinical benefits may take 6-12 hours to appear 2, 5
    • Continue high-dose steroids: prednisolone 30-60 mg daily or IV hydrocortisone 200 mg every six hours 1
    • Oral administration is as effective as IV administration 1
  4. For Life-Threatening Features, Add:

    • Ipratropium bromide 0.5 mg nebulized with β-agonist 1
    • Consider IV aminophylline (250 mg over 20 minutes) or IV salbutamol/terbutaline (250 μg over 10 minutes)
    • Caution: Do not give bolus aminophylline to patients already taking oral theophyllines 1

Monitoring Treatment

  1. Measure and record PEF 15-30 minutes after starting treatment and regularly thereafter
  2. Continue oxygen therapy
  3. If improving: give nebulized β-agonist every 4 hours
  4. If not improving after 15-30 minutes: give nebulized β-agonists more frequently (up to every 15 minutes)
  5. If still unsatisfactory progress: consider aminophylline or parenteral β-agonist 1

Subsequent Management

If Patient Is Improving:

  • Continue high-flow oxygen
  • Continue prednisolone 1-2 mg/kg daily (maximum 40 mg)
  • Continue nebulized β-agonist 4-hourly 1

If Patient Is Not Improving After 15-30 Minutes:

  • Continue oxygen and steroids
  • Give nebulized β-agonist more frequently (up to every 30 minutes)
  • Add ipratropium to nebulizer and repeat 6-hourly until improvement starts 1

Criteria for ICU Transfer

Transfer to intensive care unit (accompanied by a doctor prepared to intubate) if:

  • Deteriorating PEF
  • Worsening exhaustion, feeble respirations
  • Persistent hypoxia or hypercapnia
  • Coma, respiratory arrest, confusion, or drowsiness 1

Mechanical Ventilation

If respiratory failure develops despite maximal therapy:

  • The ventilation strategy should aim to avoid dynamic hyperinflation by enhancing expiratory time
  • Complications to watch for include hypotension and barotrauma
  • Sedation with opioids, benzodiazepines, or propofol may be required to facilitate ventilator synchrony
  • Avoid neuromuscular blockade if possible due to risk of myopathy 3

Discharge Criteria

Patients should only be discharged when:

  • They have been on discharge medication for 24 hours with inhaler technique checked
  • PEF >75% of predicted or best and PEF diurnal variability <25%
  • Treatment includes oral steroids and inhaled steroids in addition to bronchodilators
  • They have a PEF meter and self-management plan
  • Follow-up with primary care is arranged within 1 week 1

Common Pitfalls to Avoid

  1. Underestimating severity: The severity of asthma attacks is often underestimated by patients, relatives, and doctors 1

  2. Delaying corticosteroids: Administer systemic corticosteroids early as benefits may take 6-12 hours to appear 2

  3. Inappropriate sedation: Any sedation is contraindicated in status asthmaticus 1

  4. Overuse of antibiotics: Give antibiotics only if bacterial infection is present 1

  5. Inadequate monitoring: Physicians' subjective assessments of airway obstruction are often inaccurate; use objective measures like PEF and pulse oximetry 2

  6. Premature discharge: Ensure patients meet all discharge criteria and have a clear follow-up plan 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Chapter 14: Acute severe asthma (status asthmaticus).

Allergy and asthma proceedings, 2012

Research

Management of respiratory failure in status asthmaticus.

American journal of respiratory medicine : drugs, devices, and other interventions, 2002

Research

Acute severe asthma (status asthmaticus).

Allergy and asthma proceedings, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.